A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/495 (2006.01) A61K 31/19 (2006.01) A61K 47/12 (2006.01) A61K 47/18 (2006.01) A61K 47/26 (2006.01)
Patent
CA 2210076
The present invention relates to novel injection and infusion solutions of the following composition: a) 0.1 to 20% by weight of enrofloxacin, based on the total weight of the solution, in the form of its salts with polyhydroxycarboxylic acids or amino acids or mixtures thereof, b) polyhydroxycarboxylic acids, amino acids or mixtures thereof in 0.1 to 5 molar excess, based on enrofloxacin; c) optionally 0.1 to 30% by weight of formulation aids, based on the total weight of the solution; d) water to 100% by weight.
La présente invention concerne de nouvelles solutions d'injection ou de perfusion dont la composition est la suivante: a) 0,1 à 20 % en poids d'enrofloxacine par rapport au poids total de la solution sous forme de ses sels avec des acides polyhydroxycarboxyliques ou des acides aminés ou bien leurs mélanges; b) des acides polyhydroxycarboxyliques, des acides aminés ou leurs mélanges en excès molaire de 0,1 à 5 par rapport à l'enrofloxacine; c) éventuellement 0,1 à 30 % en poids d'auxiliaires de formulation par rapport au poids total de la solution; d) de l'eau pour totaliser 100 % en poids.
Bonse Gerhard
Hamm Martin
Muller Hanns-Peter
Naik Arundev Haribhai
Scheer Martin
Aktiengesellschaft Bayer
Bayer Animal Health Gmbh
Fetherstonhaugh & Co.
LandOfFree
Enrofloxacin injection or infusion solutions does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Enrofloxacin injection or infusion solutions, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Enrofloxacin injection or infusion solutions will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1732279